Research Interests:The research program of Dr. Stephen Pang is on the structure and function of the cardiovascular system in health and disease. His current research focus is on the design of gene therapies for the treatment of myocardial infarction (MI or heart attack). Using atrial natriuretic peptide (ANP) as a cardioprotective molecule, Dr. Pang’s laboratory is designing a new gene construct in order to protect the heart immediately following MI. With the collaboration of Drs. Yat Tse, Luis Melo and Christopher Ward (Physiology), Dr. Pang is evaluating methods for developing a stem cell-based therapy for MI. Drs. Brian Amsden (Chemical Engineering) and Pang are developing a method of delivering hepatic growth factor as a means to treat MI. Drs. Stephen Waldman (Mechanical Engineering) and Pang are current working on methods of producing engineered articular cartilage for implantation and joint repair.
Sources of Research Funds: Heart and Stroke Foundation; Canadian Institutes of Health Research.